The role of platelets in progressive glomerulosclerosis: Mechanisms for intraglomerular platelet activation and pathogenetic consequences

Medical Hypotheses

Volumn 28, Issue 1, 1989, Pages 51-56

  Clark, W F ^a   Naylor, C D ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; FEMALE; GLOMERULOSCLEROSIS; HUMAN; MALE; THROMBOCYTE ACTIVATION;

ANIMAL; BLOOD PLATELETS; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL; HEMODYNAMICS; HUMAN; KIDNEY GLOMERULUS; MICROCIRCULATION;

EID: 0024552076     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-9877(89)90153-9     Document Type: Article

References (56)

1. Altered glomerular permselectivity and progressive sclerosis following extensive ablation of renal mass
2. Dietary protein intake and the progressive return of kidney disease. The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerulosclerosis in aging, renal ablation and intrinsic renal disease
3. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
4. Dynamics of glomerular ultrafiltration. VII: Response to reduced renal mass
5. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation
6. Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction
7. Experimental model of focal sclerosis. II. Correlation with immunopathological changes, macromolecular kinetics, and polyanion loss
8. Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction
9. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass
10. Pathogenesis of the glomerulopathy associated with renal infarction in rats
11. Role of heparin as a protective agent following reduction of renal mass
12. Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats
13. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation
14. Glomerular basement membrane. Studies on its structure and interaction with platelets
15. Models of the destruction of blood platelets
16. The induction of the release reaction in human blood platelets by close cell contact
17. Spontaneous aggregates of immunoglobulin G prime the human platelet release reaction induced by close cell contact
18. Human glomeruli release fatty acids which stimulate thromboxane synthesis in platelets
19. Quantitative assessment of procoagulant activity in isolated rat glomeruli
20. Platelet dependent serum factor that stimulates the proiferation of arterial smooth muscle cells in vitro
21. Influence of human platelet factors on the proliferation of rat mesangial glomerular cells
22. Platelet cationic proteins are present in glomeruli of lupus nephritis patients
23. Binding of platelet factor 4 to glomerular polyanion
24. Platelet activating factor-induced loss of glomerular anionic charges
25. Characterization of human platelet vascular permeability-enhancing activity
26. Platelets and initiation of intrinsic clotting
27. Relationship between platelet serotonin and prothrombin cleavage in native whole blood
28. The role of platelets in glomerulonephritis
29. Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits
30. Renal lesions and rise in blood pressure caused by adenosine diphosphate-induced platelet aggregation in rabbits
31. Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic uremic syndrome): clinicopathologic study in 20 adults
32. Platelet destruction in renal disease
33. Pathogenic significance of platelet activation in lupus nephritis
34. Immunologic findings, thrombocytopenia, and disease activity in lupus nephritis
35. Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus
36. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance
37. Platelet-aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus
38. Thrombotic tendency in systemic lupus erythematosus
39. Mechanism of intra-renal platelet release
40. Spontaneous aggregates of native immunoglobulins in serum
41. Age-related incidence of sclerotic glomeruli in human kidneys
42. The case for intra-renal hypertension in the initiation and progression of diabetes and other glomerulopathies
43. Pathogenesis of diabetic microangiopathy. The hemodynamic view
44. A kinetic evaluation of haemostasis in renal disease
45. Increased urinary beta-thromboglobulin excretion in diabetes
46. Diabetic nephropathy
47. Thromboxane production and platelet aggregation in diabetic subjects with clinical complications
48. Platelets and diabetes mellitus
49. Circulating immune complexes in diabetics with severe microangiopathy: Evaluation by two different methods
50. Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy
51. Immunological mechanisms in diabetic microangiopathy: Immune complexes related to insulin treatment, platelet factors and lymphocytes
52. Is hyperviscosity a treatable component of diabetic microcirculatory disease?
53. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi
54. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats
55. Determinants of glomerular filtration and plasma flow in experimental diabetic rats
56. Glomerular haemodynamic and structural correlations in long term experimental diabetic rats